Follicular Lymphoma  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00556127: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

Completed
2
94
Europe
Rituximab, Epirubicin, Cyclophosphamide, Vincristine, Prednisone, Granulocyte-colony-stimulating factor, Mitoxantrone, Cytarabine ARA-C, Dexamethasone, Carmustine BCNU, Etoposide, Melphalan, Radiotherapy, PBSC reinfusion
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS
 
09/06
NCT05572983: Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Recruiting
2
47
RoW
Chidamide combined with CHOP, Induction treatment, Chidamide, Maintenance treatment
Sun Yat-sen University
Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
09/24
09/26

Download Options